SAN DIEGO--(BUSINESS WIRE)--Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company’s new platform for non-invasive in situ live cell imaging. The Celigo Cytometer provides unsurpassed speed, flexibility and precision of cellular analysis across a wide range of applications, including cell health assays, cell culture maintenance, toxicity assays and assays for detecting the highest antibody-secreting cells within a population.
